Table 1. Demographic, clinical characteristics, treatment outcomes and receipt of CCT of people enrolled in the study, 2014–2021, Zimbabwe.

Characteristic		Total	Received ≥1 CCT N (%)	Prevalence ratio for receiving CCT (95% CI)
		481	254 (53)⁑
Sex	Male	292	150 (51)	0.93 (0.79–1.11)
	Female	189	104 (55)	Reference
HIV status	Positive	369	188 (51)	0.86 (0.71–1.04)
	Negative	103	61 (59)	Reference
	Unknown	9
History of TB	Previously treated	165	91(55)	1.06 (0.89–1.26)
	New	286	149 (52)	Reference
	Unknown	30
Age category	≤20	23	12 (52)	Reference
	21–34	186	104 (56)	1.07 (0.71–1.62)
	35–54	228	115 (50)	0.97 (0.64–1.46)
	≥55	44	23 (52)	1.00 (0.62–1.62)
Province	Bulawayo	168	102 (61)	Reference
	Harare	78	34 (44)	0.72 (0.54–0.95)
	Matebeleland South	137	64 (47)	0.77 (0.62–0.96)
	Masvingo	98	54 (55)	0.91 (0.73–1.12)
Treatment regimen	18–24 months	380	192 (51)	0.82 (0.64–0.99)
	9–12 months	101	62 (61)	Reference
Year of treatment initiation	2014–2015	74	47 (64)	Reference
	2016–2017	158	84 (53)	0.84 (0.67–1.05)
	2018–2019	184	77 (42)	0.66 (0.52–0.84)
	2020–2021	65	46 (71)	1.11 (0.88–1.41)
Treatment outcomes	Successful	262	186 (71)	2.28 (1.85–2.83)
	Unsuccessful	219	68 (31)	Reference
Died/LTFU< 3mo	Yes	119	21 (18)	0.27 (0.18–0.41)
	No	362	233 (64)	Reference

CCT = Conditional cash transfer; CI = Confidence interval; LTFU = Loss to follow up;

^⁑ = Row percentage.